Breaking Down THK Co., Ltd. Financial Health: Key Insights for Investors

Breaking Down THK Co., Ltd. Financial Health: Key Insights for Investors

JP | Industrials | Industrial - Machinery | JPX

THK Co., Ltd. (6481.T) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Dive into THK Co., Ltd.'s recent financial snapshot where consolidated nine‑month revenue rose to ¥268,227 million while the company trimmed its fiscal‑year revenue forecast to ¥360,000 million (down from ¥363,500 million) and non‑consolidated revenue was revised to ¥141,400 million; profitability shows strain with operating income sliding 24.7% to ¥9,728 million and profit attributable to owners down 42.8% to ¥5,254 million, driving operating and net margins to about 3.6% and 2.0% respectively and a comprehensive loss of ¥1,715 million; the balance sheet remains conservative - total assets of ¥515,511 million, equity of ¥323,064 million and an equity ratio of 62.7% with total debt around ¥70,000 million (debt‑to‑equity ~0.22) - while liquidity metrics (current ratio ≈2.0, quick ratio ≈1.5, cash ratio ≈0.8) and free cash flow of ¥6.09 billion support stability even as U.S. tariffs and restructuring costs pressure margins; market valuation shows a share price of ¥4,186 and market cap ≈¥468.92 billion with a trailing P/E of 74.41, forward P/E 21.96, TTM EPS ¥56.26, dividend yield 5.88% and beta 0.33, and analysts point to a potential rebound - management projects ¥381.8 billion in revenue for 2026 (a 7.3% increase) and forecasts EPS of ¥190 (a 227% jump) - read on to unpack what these figures mean for investors assessing risk, value and upside potential

THK Co., Ltd. (6481.T) - Revenue Analysis

Consolidated and non-consolidated revenue trends for THK Co., Ltd. (6481.T) through the nine months ended September 30, 2025, and the revised fiscal-year forecasts show mixed momentum: modest top-line growth but pressure on margins and order intake in key regions.

  • Consolidated revenue (9 months to Sep 30, 2025): ¥268,227 million - up 1.2% YoY, driven primarily by recovery in industrial machinery demand in China and the US.
  • Revised consolidated FY 2025 revenue forecast: ¥360,000 million (previous guidance: ¥363,500 million) - lowered due to weaker-than-expected orders in Japan and Europe.
  • Revised non-consolidated FY 2025 revenue forecast: ¥141,400 million (initial forecast: ¥150,000 million) - reflecting domestic industrial machinery challenges.
Metric Period / Forecast Amount (¥ million) Change
Consolidated Revenue (9M) Jan-Sep 2025 268,227 +1.2% YoY
Consolidated Revenue (FY Forecast) FY 2025 (revised) 360,000 ↓ from 363,500
Non-consolidated Revenue (FY Forecast) FY 2025 (revised) 141,400 ↓ from 150,000
Gross Profit Margin 9M to Sep 30, 2025 22.4% Stable
Dividend (Total per share) FY 2025 (projection) ¥246 Policy maintained

Key drivers, risks, and operational signals:

  • Geographic drivers: China and the US contributed to the consolidated top-line recovery; Japan and Europe saw softer orders prompting downward revision.
  • Margin and cost dynamics: Gross profit margin at 22.4% for the nine-month period indicates resilience in product-level profitability, but the company's note of declining profits suggests rising operating costs or weaker operating leverage.
  • Cash-return signal: Management maintained a total annual dividend of ¥246 per share, signaling a continued shareholder-return focus despite forecast reductions.
  • Order-book and backlog risk: Revised revenue guidance and lower non-consolidated targets point to near-term demand headwinds in the domestic industrial machinery segment.

For context on strategic positioning and corporate priorities that may affect future revenue mix and recovery pathways, see: Mission Statement, Vision, & Core Values (2026) of THK Co., Ltd.

THK Co., Ltd. (6481.T) - Profitability Metrics

THK Co., Ltd. reported a notable deterioration in profitability for the nine months ended September 30, 2025, driven by structural reform costs, U.S. tariffs and equity-method losses. Key headline figures show declines across operating income, net profit and comprehensive results versus the prior-year period.
Metric 9M Sept 30, 2025 9M Sept 30, 2024 YoY Change Margin (2025 vs 2024)
Operating income ¥9,728 million ¥12,925 million -24.7% Operating margin: 3.6% vs 4.9%
Profit attributable to owners of the parent ¥5,254 million ¥9,178 million -42.8% Net profit margin: 2.0% vs 3.5%
Comprehensive income / (loss) ¥(1,715) million ¥14,482 million - Significant swing to loss
  • Operating income margin compressed to ~3.6% from 4.9% a year earlier, reflecting margin pressure on core operations.
  • Net profit margin declined to ~2.0% from 3.5%, showing weaker bottom-line conversion of revenue.
  • Comprehensive loss of ¥1,715 million highlights non-operating and other comprehensive impacts (including equity-method losses and FX or valuation items).
Primary drivers and near-term implications include:
  • Structural reform costs: one-time and transitional charges reducing operating profit in 2025.
  • U.S. tariffs and trade frictions: increased input costs and selling-price pressure in key markets.
  • Equity-method losses: adverse results from affiliates amplifying the decline in profit attributable to owners.
For historical context and broader corporate background, see THK Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

THK Co., Ltd. (6481.T) - Debt vs. Equity Structure

  • Total assets (June 30, 2025): ¥515,511 million
  • Total equity (June 30, 2025): ¥323,064 million
  • Equity ratio (June 30, 2025): 62.7%
  • Total debt (June 30, 2025): ¥70,000 million
  • Debt-to-equity ratio (June 30, 2025): ≈ 0.22
Metric Value (¥ million) Calculated Ratio / Note
Total assets (Jun 30, 2025) 515,511 -
Total equity (Jun 30, 2025) 323,064 Equity ratio = 323,064 / 515,511 = 62.7%
Total debt (Jun 30, 2025) 70,000 Debt-to-equity = 70,000 / 323,064 ≈ 0.22
  • The equity ratio of 62.7% demonstrates a conservative capital structure and a strong equity base supporting operations and growth.
  • A debt-to-equity ratio of ~0.22 (well below 0.5) indicates low financial leverage and limited balance-sheet risk from borrowings.
  • The reported decreases in total assets and equity versus December 31, 2024 point to a reduction in financial leverage and a modest contraction in balance-sheet scale.
  • Stable, manageable debt levels suggest THK has maintained a balanced financing approach-relying more on equity than on new debt for capital needs.
Mission Statement, Vision, & Core Values (2026) of THK Co., Ltd.

THK Co., Ltd. (6481.T) - Liquidity and Solvency

THK's balance-sheet indicators through mid-2025 show a solid short-term liquidity cushion and sufficient cash generation to support operations and obligations.

  • Current ratio (June 30, 2025): ~2.0 - short-term assets roughly double current liabilities.
  • Quick ratio (June 30, 2025): ~1.5 - immediate liquidity excluding inventories remains strong.
  • Cash ratio (June 30, 2025): ~0.8 - cash & cash equivalents cover ~80% of current liabilities.
  • Free cash flow (9 months ended Sep 30, 2025): ¥6.09 billion - positive operational cash generation.
  • Net change in cash (quarter ended Jun 30, 2025): ¥5.30 billion - notable inflow for the quarter.

These metrics point to a company able to meet short-term obligations while maintaining operational flexibility and investing as needed.

Metric Value Period / Date
Current Ratio 2.0 June 30, 2025
Quick Ratio 1.5 June 30, 2025
Cash Ratio 0.8 June 30, 2025
Free Cash Flow ¥6.09 billion 9 months ended Sep 30, 2025
Net Change in Cash (quarter) ¥5.30 billion Quarter ended Jun 30, 2025
  • Implication: liquidity ratios above 1.0 across the board indicate comfortable short-term coverage.
  • Cash generation: positive free cash flow and quarter cash increases support reinvestment or deleveraging options.
  • Solvency context: with these liquidity measures, long-term obligations are less likely to stress near-term balance-sheet stability.

For broader context on THK's corporate background and strategic positioning, see THK Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

THK Co., Ltd. (6481.T) - Valuation Analysis

THK's market pricing as of December 12, 2025 reflects a mix of premium current valuation and expectations for near-term earnings improvement, along with shareholder income via dividends and low market volatility for risk-conscious investors.
  • Market price: ¥4,186 per share (12-Dec-2025)
  • Market capitalization: ≈ ¥468.92 billion
  • Trailing P/E: 74.41
  • Forward P/E: 21.96
  • Trailing twelve months (TTM) EPS: ¥56.26
  • Dividend yield: 5.88%
  • Beta (volatility): 0.33
Metric Value Implication
Share Price (12-Dec-2025) ¥4,186 Current market pricing baseline
Market Capitalization ¥468.92 billion Mid-cap scale on Tokyo exchange
Trailing P/E 74.41 High multiple vs. historical averages - premium for current earnings
Forward P/E 21.96 Market expects material EPS growth or normalization
TTM EPS ¥56.26 Reported profitability over last 12 months
Dividend Yield 5.88% Attractive current income for shareholders
Beta 0.33 Lower volatility than broader market; defensiveness
Market context and quick interpretive notes:
  • The wide gap between trailing P/E (74.41) and forward P/E (21.96) implies either recent one-off earnings weakness or anticipated recovery/earnings acceleration; validate by reviewing recent quarterly drivers of EPS and company guidance.
  • A 5.88% dividend yield materially enhances total shareholder return prospects, especially combined with a low beta (0.33) for investors prioritizing income and stability.
  • Given a market cap near ¥469 billion, liquidity and institutional coverage are sufficient for active engagement, but valuation comparables within industrial/mechanical components should be analyzed to confirm the premium.
For investor background and positioning context, see: Exploring THK Co., Ltd. Investor Profile: Who's Buying and Why?

THK Co., Ltd. (6481.T) - Risk Factors

The following risk factors materially affect THK Co., Ltd.'s financial health and outlook for the fiscal year ending December 31, 2025:
  • Weaker-than-expected orders in key markets - Japan and Europe - have forced management to revise revenue forecasts for FY2025, reducing top-line visibility and increasing downside risk to guidance.
  • U.S. tariffs on relevant industrial components and materials have raised operational costs, compressing gross and operating margins across affected product lines.
  • Structural reforms driven by the new management policy of "Early Realization of ROE over 10%" have generated one-time and ongoing implementation costs, weighing on near‑term profitability.
  • Profitability deterioration: rising input and tariff-related costs combined with weaker demand make margin recovery uncertain in the short term.
  • Receipt of a comprehensive loss for the nine months ended September 30, 2025 raises concerns about meeting full-year profitability targets and restoring investor confidence.
Metric Value Period
Comprehensive income / (loss) ¥‑1,715 million (loss) Nine months ended Sep 30, 2025
Comprehensive income ¥14,482 million Nine months ended Sep 30, 2024
Management ROE target Over 10% Policy target
Primary risk drivers Lower orders (Japan, Europe); U.S. tariffs; restructuring costs FY2025
  • Liquidity and capital allocation: Persistent operating losses could force THK to prioritize cash preservation, delaying capital expenditures or strategic investments intended to improve long‑term ROE.
  • Market sensitivity: Given the concentration of order weakness in industrial machinery, further softness in capital goods demand could lead to additional revenue downgrades.
  • Execution risk on reforms: Achieving "Early Realization of ROE over 10%" depends on successful cost controls, margin recovery, and order stabilization; misexecution will exacerbate financial strain.
For more background on shareholder composition and investor interest, see: Exploring THK Co., Ltd. Investor Profile: Who's Buying and Why?

THK Co., Ltd. (6481.T) - Growth Opportunities

THK Co., Ltd. (6481.T) is positioned to capitalize on a cyclical recovery in industrial machinery and demand for precision motion components. Management's projections and analyst expectations point to measurable near-term improvements in top-line and bottom-line performance, supported by strategic initiatives in operations, markets, and technology.
  • Projected revenue for FY2026: ¥381.8 billion, a 7.3% increase from the prior year, driven largely by recovery in industrial machinery demand.
  • Analyst consensus for EPS in FY2026: ¥190, representing a 227% increase - signaling expectations of improved profitability and margin recovery.
  • Ongoing structural reforms aimed at streamlining operations to improve operational efficiency and return on equity (ROE).
  • Targeted expansion into emerging markets to diversify revenue streams and mitigate geographic concentration risk.
  • Increased R&D spending to develop innovative motion control and linear guide technologies for new market segments (e.g., robotics, semiconductor equipment, medical devices).
  • Strengthening partnerships with key clients and suppliers to secure long-term contracts and improve supply chain resilience.
Metric FY2025 (Actual / Estimate) FY2026 (Projected) Change
Revenue (¥ billion) ¥355.9 ¥381.8 +7.3%
Earnings Per Share (¥) ¥58 (estimate) ¥190 (analyst forecast) +227%
Primary Growth Drivers Recovery in industrial machinery, existing product sales Market recovery, new product launches, emerging market expansion Operational & market diversification
R&D Investment Focus Linear motion, actuators, control systems Advanced robotics components, semiconductor manufacturing solutions Product innovation
Strategic Initiatives Cost restructuring, supply-chain optimization Structural reforms, strategic partnerships, market expansion Efficiency & growth
Key actionable areas for investors to monitor:
  • Execution of structural reforms - watch SG&A trends, margins, and ROE improvement.
  • Revenue composition by region - pace of recovery in core industrial markets versus growth in emerging markets.
  • R&D milestones and product commercialization timelines that could unlock higher-margin sales.
  • Announced partnerships, supply agreements, or long-term contracts with major OEMs that could stabilize revenue.
  • Quarterly guidance versus analyst expectations, particularly EPS trajectory toward the ¥190 2026 forecast.
For further background on investor composition and buying trends, see: Exploring THK Co., Ltd. Investor Profile: Who's Buying and Why?

DCF model

THK Co., Ltd. (6481.T) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.